Treatment Breakthroughs Advance Care Across Heterogeneous NSCLC Population

Kwok-Kin Wong, MD, PhD, discusses updates in non–small cell lung cancer and the importance of enrolling patients in clinical trials to further progress the field.

More From BioPortfolio on "Treatment Breakthroughs Advance Care Across Heterogeneous NSCLC Population"